Search details
1.
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Lancet Oncol
; 25(5): 668-682, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38552658
2.
MR multitasking-based dynamic imaging for cerebrovascular evaluation (MT-DICE): Simultaneous quantification of permeability and leakage-insensitive perfusion by dynamic T 1 / T 2 * mapping.
Magn Reson Med
; 89(1): 161-176, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36128892
3.
Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.
Pediatr Blood Cancer
; 69(10): e29830, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35686831
4.
A genome-wide association study on medulloblastoma.
J Neurooncol
; 147(2): 309-315, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32056145
5.
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
J Neurooncol
; 145(2): 375-383, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31621042
6.
Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.
Pediatr Blood Cancer
; 66(12): e27983, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31502379
7.
A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
J Neurooncol
; 140(3): 575-582, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30173409
8.
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.
J Neurooncol
; 138(1): 199-207, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29427149
9.
Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.
Pediatr Blood Cancer
; 67(12): e28516, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32573959
10.
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
J Clin Oncol
; 42(12): 1340-1343, 2024 Apr 20.
Article
in English
| MEDLINE | ID: mdl-38394473
11.
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
Neurooncol Pract
; 11(2): 188-198, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38496907
12.
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
Neuro Oncol
; 25(1): 199-210, 2023 01 05.
Article
in English
| MEDLINE | ID: mdl-35604410
13.
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Cell Genom
; 3(7): 100340, 2023 Jul 12.
Article
in English
| MEDLINE | ID: mdl-37492101
14.
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.
Neuro Oncol
; 24(11): 1964-1975, 2022 11 02.
Article
in English
| MEDLINE | ID: mdl-35397478
15.
IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
Brain Pathol
; 31(4): e12959, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33960568
16.
Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.
Neurooncol Adv
; 3(1): vdab037, 2021.
Article
in English
| MEDLINE | ID: mdl-33948563
17.
Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.
Oncotarget
; 10(4): 551-557, 2019 Jan 11.
Article
in English
| MEDLINE | ID: mdl-30728904
18.
Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.
Oncotarget
; 14: 502, 2023 May 19.
Article
in English
| MEDLINE | ID: mdl-37204254
19.
Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
Neuro Oncol
; 18(1): 126-31, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26254476
20.
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas.
Sci Transl Med
; 8(366): 366ra161, 2016 11 23.
Article
in English
| MEDLINE | ID: mdl-27881822